---
title: "Intracranial Hemorrhage"
order: 1
category: "Neurosurgery"
---

# Intracranial Hemorrhage

## Overview

Intracranial hemorrhage encompasses bleeding within the cranial vault, including epidural hematoma (EDH), subdural hematoma (SDH), intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), and intraventricular hemorrhage (IVH). These conditions represent neurosurgical emergencies requiring rapid diagnosis and treatment to prevent secondary brain injury from mass effect, elevated intracranial pressure, and herniation. Understanding the pathophysiology, imaging characteristics, and surgical indications for each type is critical for optimal outcomes.

## Intracranial Pressure Dynamics

### Monro-Kellie Doctrine

**Principle**
- Cranial vault is a rigid, fixed-volume compartment containing:
  - **Brain parenchyma**: 80%
  - **Blood**: 10%
  - **Cerebrospinal fluid (CSF)**: 10%
- Increase in one compartment requires decrease in others to maintain normal intracranial pressure (ICP)

**Normal ICP**
- Adults: 5-15 mmHg
- Children: 3-7 mmHg
- Infants: 1.5-6 mmHg

**Intracranial Hypertension**
- ICP >20 mmHg sustained: Associated with poor outcomes
- Critical threshold: ICP >25 mmHg

### Cerebral Perfusion Pressure (CPP)

**Formula**
- CPP = MAP - ICP
- MAP: Mean arterial pressure
- ICP: Intracranial pressure

**Target CPP**
- Adults: 60-70 mmHg
- Pediatric: Age-dependent (40-50 mmHg in infants, 50-60 in children)

**Cerebral Blood Flow (CBF)**
- Normal: 50 mL/100g/min
- Autoregulation maintains CBF across MAP 50-150 mmHg
- **Ischemic threshold**: CBF <20 mL/100g/min
- **Infarction threshold**: CBF <10 mL/100g/min

### Herniation Syndromes

**Uncal Herniation**
- Medial temporal lobe (uncus) herniates through tentorial notch
- Compresses:
  - **Oculomotor nerve (CN III)**: Ipsilateral fixed dilated pupil
  - **Posterior cerebral artery**: Occipital infarction
  - **Midbrain**: Contralateral hemiparesis (or ipsilateral if Kernohan's notch)
- **Classic triad**: Ipsilateral pupil dilation, contralateral hemiparesis, decreased consciousness

**Central Herniation**
- Downward displacement of diencephalon and midbrain
- **Presentation**: Progressive stupor, small reactive pupils, Cheyne-Stokes respirations, decorticate then decerebrate posturing

**Subfalcine Herniation**
- Cingulate gyrus herniates under falx cerebri
- Compresses anterior cerebral artery → leg weakness

**Tonsillar Herniation**
- Cerebellar tonsils through foramen magnum
- Compresses medulla → respiratory arrest, bradycardia

**Upward Transtentorial Herniation**
- Posterior fossa mass pushes cerebellar vermis upward
- Compresses midbrain and aqueduct

## Epidural Hematoma (EDH)

### Pathophysiology

**Mechanism**
- Traumatic injury causing skull fracture
- Disruption of middle meningeal artery (MMA) or dural venous sinus
- Blood accumulates between skull and dura (potential space)

**Location**
- **Temporal region** (most common, 75%): Middle meningeal artery injury
- **Frontal**: Anterior meningeal artery or dural sinus
- **Posterior fossa**: Venous sinus injury (transverse, sigmoid)

**Arterial vs. Venous**
- **Arterial**: Rapid expansion, early symptoms
- **Venous**: Slower accumulation, delayed presentation

### Clinical Presentation

**Classic History**
- Traumatic impact with loss of consciousness
- **"Lucid interval"**: Temporary recovery (30-50% of cases)
- Subsequent deterioration: Headache, vomiting, declining consciousness

**Examination**
- Glasgow Coma Scale (GCS): Variable (3-15)
- Ipsilateral fixed dilated pupil (uncal herniation)
- Contralateral hemiparesis
- Cushing's triad (late):
  - Hypertension
  - Bradycardia
  - Irregular respirations (respiratory depression)

### Diagnostic Evaluation

**CT Head (Non-Contrast)**
- **Appearance**: Biconvex (lentiform) hyperdense collection
- Does not cross suture lines (limited by dural attachments)
- May cross midline at falx
- Associated skull fracture (85-95%)
- Mass effect: Midline shift, ventricular compression, effacement of sulci
- Herniation signs

**Imaging Features**
- **Acute**: Hyperdense (60-80 HU)
- **Subacute** (3-21 days): Isodense
- **Chronic** (>3 weeks): Hypodense

### Surgical Indications

**Absolute Indications**
- EDH volume >30 mL
- EDH thickness >15 mm
- Midline shift >5 mm
- GCS ≤8 with pupillary abnormality
- Neurological deterioration

**Relative Indications**
- EDH in posterior fossa (any size, high risk of herniation)
- Progressive enlargement on serial imaging
- Elevated ICP refractory to medical management

**Observation Criteria** (All must be met)
- EDH volume <30 mL
- Thickness <15 mm
- Midline shift <5 mm
- GCS >8, no focal deficit
- No posterior fossa involvement
- Neurosurgical availability, ICU monitoring, rapid access to OR
- Reliable serial neurologic exams and repeat imaging

### Surgical Technique

**Craniotomy for EDH Evacuation**

**Preparation**
- General anesthesia, endotracheal intubation
- Position: Supine with head turned (temporal EDH)
- Clamp operative site hair (do not shave)
- Antibiotics: Cefazolin or cefuroxime

**Technique**
1. **Incision**: Curvilinear or question mark (temporal)
2. **Craniotomy**: Center over hematoma
   - Burr holes at corners of planned bone flap
   - Craniotome to connect burr holes
   - Elevate bone flap (attached to temporalis muscle or free flap)
3. **Dural elevation**: Hematoma under pressure, evacuates rapidly
4. **Hemostasis**:
   - Identify bleeding source (MMA, dural sinus, bone edge)
   - MMA: Bipolar cautery, clips, bone wax
   - Dural sinus: Hemostatic agents, sutures, packing
   - Bone edges: Bone wax
5. **Dural tacking sutures**: Prevent recurrence, secure dura to bone edges
6. **Closure**:
   - Replace bone flap (or leave off if severe edema)
   - Secure with plates or sutures
   - Layered soft tissue closure
   - Subgaleal drain optional

**Decompressive Craniectomy**
- If severe brain swelling
- Leave bone flap out, dural augmentation
- Cranioplasty at later date (3-6 months)

### Postoperative Management

**ICU Monitoring**
- Neurologic examination: Hourly initially
- ICP monitoring: If indicated (GCS ≤8, diffuse edema)
- Maintain CPP 60-70 mmHg
- Serial CT: Post-op, then as clinically indicated

**ICP Management**
- Head of bed elevation (30°)
- Avoid hypotension (SBP >90 mmHg)
- Normocapnia (pCO2 35-40 mmHg)
- Osmotic therapy: Mannitol 0.25-1 g/kg or hypertonic saline (3% or 23.4%)
- Sedation and analgesia
- Seizure prophylaxis: Levetiracetam 7 days

**Mobilization**
- Out of bed when stable
- Physical and occupational therapy

### Complications

**Intraoperative**
- Uncontrolled bleeding (MMA, venous sinus)
- Brain injury during evacuation
- Air embolism (venous sinus injury)

**Postoperative**
- **Recurrent hematoma** (5-10%): May require re-operation
- **Seizures** (10-15%): Prophylaxis indicated
- **Infection** (2-5%): Wound infection, meningitis, brain abscess
- **CSF leak**: Dural tear, may require repair
- **Tension pneumocephalus**: Air under pressure, "Mount Fuji sign"

### Outcomes

**Favorable Outcomes**
- **Good neurologic recovery**: 85-90% if evacuated promptly
- **Mortality**: 5-10% overall (higher if delayed, comatose, herniation)

**Poor Prognostic Factors**
- GCS ≤8 on admission
- Fixed dilated pupils
- Delayed surgery (>4 hours)
- Age >60 years
- Large hematoma volume (>100 mL)

## Subdural Hematoma (SDH)

### Pathophysiology

**Mechanism**
- Disruption of bridging veins between cortex and dural venous sinuses
- Blood accumulates in subdural space (between dura and arachnoid)
- Commonly associated with acceleration-deceleration injury

**Risk Factors**
- Advanced age (cerebral atrophy, stretched bridging veins)
- Anticoagulation (warfarin, DOACs, antiplatelet agents)
- Chronic alcohol abuse
- Falls, assault
- Trivial trauma in elderly

### Classification

**Acute SDH** (<3 days)
- High-energy trauma
- Associated with underlying brain injury (contusions, diffuse axonal injury)
- Hyperdense on CT

**Subacute SDH** (3-21 days)
- Mixed density or isodense on CT
- May be difficult to visualize

**Chronic SDH** (>3 weeks)
- Low-energy trauma, often minor or unrecognized
- Hypodense on CT (similar to CSF)
- Common in elderly

### Acute Subdural Hematoma

**Clinical Presentation**
- Variable consciousness level (GCS 3-15)
- Focal neurologic deficits: Hemiparesis, aphasia
- Headache, vomiting
- Pupillary changes (uncal herniation)

**Diagnostic Evaluation**
- **CT head**: Crescentic hyperdense collection
  - Crosses suture lines (not limited by dura)
  - Does not cross midline (falx) or tentorium
  - Mass effect, midline shift
  - Underlying brain injury (contusions, edema)

**Surgical Indications**
- SDH thickness >10 mm
- Midline shift >5 mm
- GCS ≤8 with pupillary abnormality
- ICP >20 mmHg
- Neurological deterioration

**Non-Operative Management**
- Small SDH (<10 mm, <5 mm shift)
- GCS >8, no focal deficits
- No ICP elevation
- Serial imaging and exams
- Reverse coagulopathy if present

**Surgical Technique**
- **Craniotomy**: Large bone flap, dural opening
- Evacuate hematoma (irrigation, suction)
- Hemostasis: Cortical vessels, dural edge
- Leave dura open or duraplasty
- Decompressive craniectomy if severe edema
- ICP monitor placement

**Outcomes**
- **Mortality**: 40-60% (higher than EDH due to underlying brain injury)
- **Favorable outcome**: 30-50%
- **Poor prognostic factors**: GCS ≤8, age >65, pupil abnormalities, midline shift >10 mm

### Chronic Subdural Hematoma

**Clinical Presentation**
- Insidious onset, fluctuating symptoms
- Headache (most common)
- Cognitive decline, confusion
- Gait disturbance, falls
- Focal deficits: Hemiparesis (25-50%)
- Seizures (5-10%)

**Diagnostic Evaluation**
- **CT head**: Crescentic hypodense collection
  - May have septations, membranes
  - Acute-on-chronic: Mixed density (rebleeding)
  - Mass effect variable

**Natural History**
- May spontaneously resolve, remain stable, or enlarge
- Risk of rebleeding into chronic SDH (acute-on-chronic)

**Surgical Indications**
- Symptomatic (headache, deficits, cognitive changes)
- Midline shift >5 mm
- Thickness >10 mm
- Neurological deterioration

**Non-Operative Management**
- Asymptomatic, small SDH
- Poor surgical candidate
- Serial imaging

**Surgical Technique**

**Burr Hole Drainage**
- One or two burr holes (frontal and parietal)
- Dural opening, copious irrigation
- Subdural drain placement (24-48 hours)
- Bed flat postoperatively (encourage brain re-expansion)

**Twist Drill Craniostomy**
- Minimally invasive, bedside procedure
- Small bore catheter drainage
- Lower evacuation rate but less invasive

**Craniotomy**
- Reserved for:
  - Organized/septated hematoma
  - Failed burr hole drainage
  - Acute-on-chronic SDH
  - Membrane excision

**Postoperative Management**
- Bed flat or minimal elevation (12-24 hours)
- Drain removal: 24-48 hours
- Avoid anticoagulation 4-6 weeks
- Serial imaging: Rule out recurrence

**Complications**
- **Recurrence** (10-30%): May require repeat drainage
- **Tension pneumocephalus**: Excessive air accumulation, "Mount Fuji sign"
- **Seizures** (5-10%)
- **Subdural empyema** (1-2%)
- **Intracerebral hemorrhage** (rare, from brain re-expansion)

**Outcomes**
- **Good recovery**: 70-90%
- **Recurrence predictors**: Large size, bilateral, mixed density, anticoagulation, younger age

## Intracerebral Hemorrhage (ICH)

### Pathophysiology

**Etiology**

**Hypertensive ICH** (50-60%)
- Chronic hypertension → lipohyalinosis of small penetrating arteries
- **Common locations**:
  - **Basal ganglia** (putamen): 35-50%
  - **Thalamus**: 15-25%
  - **Pons**: 5-10%
  - **Cerebellum**: 5-10%
  - **Subcortical white matter** (lobar): 10-20%

**Other Causes**
- **Cerebral amyloid angiopathy (CAA)**: Elderly, lobar hemorrhages, recurrent
- **Vascular malformations**: AVM, cavernoma, aneurysm
- **Coagulopathy**: Anticoagulation (warfarin, DOACs), thrombocytopenia
- **Tumor**: Hemorrhage into primary or metastatic brain tumor
- **Drug use**: Cocaine, amphetamines, sympathomimetics
- **Trauma**: Contusion evolves into ICH
- **Moyamoya disease**: Collateral vessel rupture
- **Venous thrombosis**: Hemorrhagic venous infarction

### Clinical Presentation

**Symptoms**
- Sudden onset headache
- Altered mental status (30-50% present with GCS ≤8)
- Focal neurological deficits (location-dependent):
  - **Putamen**: Contralateral hemiparesis, hemisensory loss, gaze preference
  - **Thalamus**: Contralateral hemiparesis, hemisensory loss, gaze deviation (wrong-way eyes)
  - **Lobar**: Cortical signs (aphasia, neglect, visual field deficits)
  - **Cerebellar**: Ataxia, nystagmus, obstructive hydrocephalus
  - **Pontine**: Quadriparesis, pinpoint pupils, coma
- Seizures (10-15%, more common in lobar ICH)

**Examination**
- Blood pressure often markedly elevated (>180/120 mmHg)
- Decreased consciousness level
- Focal motor or sensory deficits
- Cranial nerve abnormalities
- Signs of herniation (late)

### Diagnostic Evaluation

**CT Head (Non-Contrast)**
- **Appearance**: Hyperdense intraparenchymal collection
- **Irregular or round morphology**
- **Perilesional edema**: Hypodense rim, develops over hours to days
- **Mass effect**: Midline shift, ventricular compression
- **Intraventricular extension (IVH)**: 30-50%, poor prognosis
- **Hydrocephalus**: Obstructive (IVH, posterior fossa ICH)

**Hematoma Expansion**
- Occurs in 30-40% within first 24 hours
- **Risk factors**: Early presentation (<3 hours), anticoagulation, irregular shape ("spot sign")
- Associated with worse outcomes

**CT Angiography (CTA)**
- "Spot sign": Contrast extravasation within hematoma (active bleeding, high expansion risk)
- Evaluate for underlying vascular malformation or aneurysm
- Especially important in young patients, lobar hemorrhage, no hypertension history

**MRI**
- Not routinely obtained acutely (time-consuming, less available)
- Useful for:
  - Chronic microbleeds (CAA, hypertensive vasculopathy)
  - Underlying tumor or vascular malformation
  - Cavernoma (blooming artifact on gradient echo)

**ICH Score** (Prognosis)
- **Components**:
  - GCS 3-4: 2 points; GCS 5-12: 1 point; GCS 13-15: 0 points
  - Age ≥80: 1 point
  - Infratentorial location: 1 point
  - ICH volume ≥30 mL: 1 point
  - IVH: 1 point
- **Total score**: 0-6
- **Mortality**: Score 0: <5%, Score 5-6: >80%

**ICH Volume Calculation**
- **ABC/2 method**: A (max diameter), B (perpendicular diameter), C (number of slices × slice thickness in cm)

### Medical Management

**Blood Pressure Management**

**Target**
- **Acute ICH (<6 hours)**: SBP 140-160 mmHg
  - INTERACT2 trial: Intensive BP lowering (SBP <140) safe and may reduce hematoma expansion
  - ATACH-II trial: No benefit of SBP <140 vs <180, but safe
- **Avoid hypotension**: SBP >120 mmHg (maintain cerebral perfusion)

**Agents**
- IV labetalol, nicardipine, clevidipine (titratable)

**Coagulopathy Reversal**

**Warfarin**
- **Vitamin K**: 10 mg IV (slow reversal, 6-24 hours)
- **Prothrombin complex concentrate (PCC)**: 4-factor PCC 25-50 units/kg (rapid reversal)
- **Fresh frozen plasma (FFP)**: Alternative if PCC unavailable (slower, volume load)
- Goal INR <1.4 within 4 hours

**Direct Oral Anticoagulants (DOACs)**
- **Dabigatran**: Idarucizumab (specific reversal agent)
- **Xa inhibitors (rivaroxaban, apixaban, edoxaban)**: Andexanet alfa (if available), PCC (off-label)

**Antiplatelet Agents**
- Consider platelet transfusion if urgent surgery planned (controversial)

**ICP Management**
- See earlier section
- Osmotic therapy, sedation, head of bed elevation
- EVD if hydrocephalus
- Surgical decompression if refractory

**Seizure Management**
- Prophylaxis not routinely recommended
- Treat clinical seizures: Levetiracetam preferred (no drug interactions)

### Surgical Indications

**General Principles**
- Surgery for ICH remains controversial
- **STICH trials**: No overall benefit of early surgery for supratentorial ICH
- **Possible benefit**: Lobar ICH within 1 cm of cortical surface

**Absolute Surgical Indications**
- **Cerebellar ICH** >3 cm diameter with:
  - Neurological deterioration
  - Hydrocephalus
  - Brainstem compression
  - Obliteration of fourth ventricle
- **Lobar ICH with deterioration**: Young patient, superficial location

**Relative Indications**
- Large lobar ICH (>30 mL) causing significant mass effect
- Accessible location (<1 cm from cortical surface)
- Young patient with salvageable neurologic function
- Underlying structural lesion requiring resection (AVM, tumor)

**Contraindications**
- Deep basal ganglia or thalamic ICH (poor outcomes, high morbidity)
- Pontine ICH (no surgical benefit)
- GCS 3-4 with no brainstem reflexes (futile)
- Small ICH (<10 mL) without mass effect

### Surgical Technique

**Craniotomy and Hematoma Evacuation**
- Approach: Based on hematoma location
- Corticectomy if needed to access deep hematoma
- Gentle suction and irrigation
- Hemostasis: Bipolar cautery, hemostatic agents
- Goal: Reduce mass effect, not complete evacuation
- ICP monitor placement

**Minimally Invasive Techniques**
- Stereotactic aspiration ± thrombolysis (MISTIE trial: investigational)
- Endoscopic evacuation
- Lower morbidity but unclear benefit

**EVD Placement**
- For IVH with hydrocephalus
- Does not evacuate ICH but treats associated hydrocephalus

### Postoperative Management

**ICU Monitoring**
- Continuous neuromonitoring
- ICP management (if monitor placed)
- Blood pressure control
- Serial CT scans

**Complications**
- Rebleeding (10-20%)
- Brain edema (peaks 3-5 days)
- Seizures
- Infection
- DVT/PE

### Outcomes

**Mortality**
- Overall: 30-50% at 30 days
- Higher with IVH, large volume, infratentorial location, low GCS

**Functional Outcomes**
- Independent function at 6 months: 20-40%
- Most improvement occurs in first 3 months
- Continued slow improvement up to 1 year

**Predictors of Poor Outcome**
- Large ICH volume (>60 mL)
- IVH
- Infratentorial location
- Low GCS (<8)
- Advanced age (>80)

## Subarachnoid Hemorrhage (SAH)

### Pathophysiology

**Etiology**

**Aneurysmal SAH** (85%)
- Rupture of intracranial aneurysm
- Blood in subarachnoid space (between arachnoid and pia)

**Non-Aneurysmal SAH**
- **Perimesencephalic SAH**: Blood around midbrain, benign, no aneurysm
- Trauma
- Vascular malformation (AVM)
- Bleeding disorder
- Cocaine, sympathomimetics

**Aneurysm Locations**
- **Anterior communicating artery (AComm)**: 30-35%
- **Posterior communicating artery (PComm)**: 25-30%
- **Middle cerebral artery (MCA) bifurcation**: 20%
- **Basilar tip**: 5-10%
- **Posterior circulation** (vertebral, PICA): 5%

### Clinical Presentation

**Classic Presentation**
- **"Worst headache of my life"**: Sudden, thunderclap onset
- Loss of consciousness (50%)
- Nausea, vomiting
- Photophobia, neck stiffness (meningismus)
- Focal neurologic deficits (30%): Cranial nerve palsies, hemiparesis
- **Terson syndrome**: Intraocular hemorrhage (vitreous or retinal)

**Examination**
- **Hunt-Hess grading**:
  - Grade 1: Asymptomatic or mild headache
  - Grade 2: Moderate-severe headache, nuchal rigidity, no deficit except CN palsy
  - Grade 3: Drowsy, confused, mild focal deficit
  - Grade 4: Stuporous, moderate-severe hemiparesis
  - Grade 5: Comatose, decerebrate posturing

**Sentinel Bleed**
- Small warning leak (10-40%)
- Mild headache days to weeks before major SAH

### Diagnostic Evaluation

**CT Head (Non-Contrast)**
- **Sensitivity**: 95-100% within 6 hours, decreases over time
- **Appearance**: Hyperdense blood in subarachnoid cisterns
  - Suprasellar cistern ("star" pattern)
  - Sylvian fissures
  - Basal cisterns
- **Fisher Grade** (vasospasm risk):
  - Grade 1: No SAH
  - Grade 2: Diffuse thin (<1 mm)
  - Grade 3: Thick clot (>1 mm) or localized
  - Grade 4: ICH or IVH, minimal SAH
  - **Grade 3 highest vasospasm risk**

**Lumbar Puncture**
- If CT negative but high clinical suspicion
- **Findings**: Red blood cells, xanthochromia (yellow CSF from bilirubin breakdown)
- Opening pressure often elevated
- Cell count: Does not clear with sequential tubes (vs. traumatic tap)

**CT Angiography (CTA)**
- Non-invasive angiography
- Identify aneurysm location, size, morphology
- Sensitivity 95-100% for aneurysms >3 mm

**Digital Subtraction Angiography (DSA)**
- Gold standard for aneurysm evaluation
- Necessary for treatment planning
- 4-vessel study (bilateral carotid and vertebral arteries)
- **Repeat if initial negative**: 10-15% initially negative DSA have aneurysm on repeat

### Complications of SAH

**Rebleeding**
- **Incidence**: 4% in first 24 hours, 15-20% in first 2 weeks
- **Mortality**: 50-80% with rebleeding
- **Prevention**: Early aneurysm securing (clipping or coiling)

**Vasospasm**
- **Incidence**: 70% on angiography, 30% symptomatic
- **Timing**: Days 3-14, peaks day 7-10
- **Mechanism**: Arterial narrowing from blood breakdown products
- **Presentation**: New focal deficit, decreased consciousness
- **Diagnosis**:
  - **Transcranial Doppler (TCD)**: Elevated velocities (>120 cm/s MCA)
  - **CT perfusion**: Decreased perfusion
  - **DSA**: Gold standard, arterial narrowing
- **Prevention**:
  - Nimodipine 60 mg PO every 4 hours × 21 days (reduces poor outcomes)
- **Treatment**:
  - **Triple-H therapy** (controversial): Hypertension, hypervolemia, hemodilution
  - **Induced hypertension**: SBP 160-200 mmHg (if aneurysm secured)
  - **Endovascular therapy**: Intra-arterial vasodilators (verapamil, nicardipine), angioplasty

**Hydrocephalus**
- **Acute**: Days 0-3, obstructive (blood in ventricles)
  - Treatment: EVD placement
- **Chronic**: Weeks to months, communicating
  - Treatment: VP shunt if symptomatic

**Seizures**
- Incidence: 10-25%
- Prophylaxis controversial (may worsen outcomes)

**Hyponatremia**
- **Cerebral salt wasting (CSW)**: Volume depletion, hyponatremia
  - Treatment: IV fluids, salt supplementation
- **SIADH**: Euvolemic hyponatremia
  - Treatment: Fluid restriction (avoid in SAH, risk of vasospasm)

### Treatment

**Aneurysm Securing**

**Surgical Clipping**
- Craniotomy and microsurgical approach
- Clip across aneurysm neck
- **Advantages**: Durable, complete exclusion, handles wide-neck aneurysms
- **Disadvantages**: Invasive, requires craniotomy, higher perioperative morbidity
- **Preferred for**: Young patients, MCA aneurysms, wide-neck aneurysms, associated ICH requiring evacuation

**Endovascular Coiling**
- Catheter-based, intra-arterial coil deployment
- Coils induce thrombosis within aneurysm sac
- **Advantages**: Less invasive, lower perioperative morbidity
- **Disadvantages**: Incomplete occlusion (10-20%), recurrence (15-30%), requires antiplatelet therapy
- **Preferred for**: Elderly, poor surgical candidates, posterior circulation aneurysms

**ISAT Trial** (2002)
- Endovascular coiling vs. surgical clipping for ruptured aneurysms
- Coiling associated with better short-term outcomes (less disability at 1 year)
- Long-term: Higher rebleeding rate with coiling, but overall outcome similar

**Adjuncts**
- **Flow diverters**: Stents that divert flow away from aneurysm (large/giant aneurysms)
- **Balloon-assisted coiling**: For wide-neck aneurysms
- **Stent-assisted coiling**: Provides scaffold for coil placement

**Timing**
- **Early** (within 24-72 hours): Preferred to prevent rebleeding
- Delayed if severe vasospasm (vasospasm peak day 7-10)

### Postoperative Management

**ICU Monitoring**
- Neurologic exams (hourly initially)
- Continuous blood pressure monitoring
- Daily TCD monitoring for vasospasm
- Serial CT scans

**Vasospasm Prevention**
- Nimodipine 60 mg PO q4h × 21 days (all patients)
- Euvolemia maintenance (avoid hypovolemia)

**Blood Pressure Management**
- Pre-aneurysm securing: SBP <160 mmHg (prevent rebleeding)
- Post-aneurysm securing: Permissive hypertension (SBP 160-200) if vasospasm

**DVT Prophylaxis**
- Sequential compression devices (early)
- Pharmacologic prophylaxis (after aneurysm secured)

### Outcomes

**Mortality**
- Overall: 40-50%
- Half die before reaching hospital

**Functional Outcomes**
- Good recovery (independent): 30-40%
- Moderate disability: 20-30%
- Severe disability or death: 30-50%

**Predictors of Poor Outcome**
- High Hunt-Hess grade (4-5)
- Advanced age
- Large aneurysm size
- Posterior circulation location
- Rebleeding or severe vasospasm

## Key Points

1. **Epidural hematoma** has a "lucid interval" in 30-50% of cases; surgical evacuation indicated if >30 mL, >15 mm thick, or midline shift >5 mm.

2. **Acute subdural hematoma** carries higher mortality (40-60%) than EDH due to associated brain injury; surgical indications include thickness >10 mm or midline shift >5 mm.

3. **Chronic subdural hematoma** is common in elderly and anticoagulated patients; burr hole drainage is effective treatment with 10-30% recurrence rate.

4. **Intracerebral hemorrhage** surgical benefit remains controversial except for cerebellar hemorrhage >3 cm with neurologic deterioration or hydrocephalus.

5. **Blood pressure control** in acute ICH: Target SBP 140-160 mmHg to reduce hematoma expansion while maintaining cerebral perfusion.

6. **Subarachnoid hemorrhage** presents with "worst headache of life"; early aneurysm securing (within 24-72 hours) prevents rebleeding (4% in first 24 hours).

7. **Vasospasm** complicates SAH in 30% symptomatically (peak day 7-10); nimodipine 60 mg q4h × 21 days reduces poor outcomes.

8. **Herniation syndromes** require immediate recognition and treatment; uncal herniation presents with ipsilateral pupil dilation and contralateral hemiparesis.

9. **ICP management** includes head of bed elevation, osmotic therapy (mannitol, hypertonic saline), and maintaining CPP 60-70 mmHg.

10. **Coagulopathy reversal** in ICH is critical: 4-factor PCC for warfarin (goal INR <1.4), idarucizumab for dabigatran, andexanet alfa for Xa inhibitors.

## References

1. Bullock MR, Chesnut R, Ghajar J, et al. Surgical management of acute epidural hematomas. Neurosurgery. 2006;58(3 Suppl):S7-15.

2. Bullock MR, Chesnut R, Ghajar J, et al. Surgical management of acute subdural hematomas. Neurosurgery. 2006;58(3 Suppl):S16-24.

3. Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032-2060.

4. Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355-2365.

5. Mendelow AD, Gregson BA, Rowan EN, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013;382(9890):397-408.

6. Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43(6):1711-1737.

7. Dorhout Mees SM, Rinkel GJ, Feigin VL, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;(3):CD000277.

8. Molyneux AJ, Kerr RS, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366(9488):809-817.

9. Santarius T, Kirkpatrick PJ, Ganesan D, et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. Lancet. 2009;374(9695):1067-1073.

10. Steiner T, Al-Shahi Salman R, Beer R, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke. 2014;9(7):840-855.
